RESUMO

The objective of the present study was to evaluate the effect of treatment with prosta-glandin F2α (PGF2α) at the beginning of the protocol for ovulation synchronization on follicular dy-namics in Bos indicus (Gyr; n=11), Bos taurus (Holstein Black and White, HBW; n=10), and crossbred animals (Gyr x HBW; n=12). On a random day of the estrous cycles (day 0, D0), the animals received 2.0 mg estradiol benzoate (EB) intramuscularly plus an intravaginal progesterone (P4) device, which was maintained for 8 days (day 8, D8). Half the heifers of each group received a dose of 25 mg PGF2αintramuscularly at the time of insertion of the intravaginal P4 device. When the intravaginal device was removed (D8), all animals received another dose of 25 mg PGF2α intramuscularly, followed by intramuscular injection of 1.0 mg EB 24 h later (day 9, D9). Ultrasonographic evaluations were per-formed at intervals of 24 hours from D0 to D8 and at intervals of 12 hours from removal of the P4 device to 96 hours thereafter. Samples were collected on days 0, 3, 6, 8, 10 and 22 for the measurement of P4. The mean maximum diameter of the dominant follicle (DF) was smaller (P=0.01) in Gyr heifers (10.0 ± 0.8 mm) than in Gyr x HBW (13.0 ± 0.6 mm) or HBW (12.5 ± 0.8 mm). Furthermore, treatment with PGF2α on D0 increased (P=0.02) the maximum diameter of DF (12.9 ± 0.5 vs. 10.9 ± 0.7 mm)...

O objetivo do presente estudo foi avaliar o efeito do tratamento com prostaglandina F2α (PGF2α)no início do protocolo de sincronização da ovulação, sobre a dinâmica folicular de novilhas Bos indicus (Gir; n=11), Bos taurus (Holandesa Preto e Branco - HPB; n=10) e cruzadas (Gir x HPB; n=12). Em dia aleatório do ciclo estral (dia 0 - D0), os animais receberam 2,0 mg de benzoato de es-tradiol (BE) via intramuscular, mais um dispositivo intravaginal de progesterona (P4) que foi man-tido por oito dias (dia 8 – D8). Metade das novilhas de cada grupo recebeu uma dose de 25 mg de PGF2α via intramuscular no momento da inserção do dispositivo intravaginal de P4. Na retirada do dispositivo intravaginal (D8), todos os animais receberam outra dose de 25 mg de PGF2α via intra-muscular e 24 h após (dia 9 - D9) receberam 1,0 mg de BE via intramuscular. Foram realizadas ava-liações ultrassonográficas com intervalos de 24 horas do D0 até o D8 e com intervalos de 12 horas da retirada do dispositivo de P4 até 96 horas. Para a dosagem de P4, foram colhidas amostras nos dias 0; 3; 6; 8; 10 e 22. A média do diâmetro máximo do folículo dominante (FD) foi menor (P=0,01) nas novilhas Gir (10,0 ± 0,8 mm) do que nas cruzadas Gir x HPB (13,0 ± 0,6 mm) ou HPB (12,5 ± 0,8 mm). Além disso, o tratamento com PGF2α no D0 aumentou (P=0,02) o diâmetro máximo do FD (12,9 ± 0,5 mm vs. 10,9 ± 0,7 mm) nos três grupamentos genéticos avaliados. A taxa de crescimento do FD foi menor (P=0,008) nas novilhas Gir (0,8 ± 0,1 mm/dia), do que nas novilhas cruzadas (1,3 ± 0,1 mm/dia) ou HPB (1,2 ± 0,1 mm/dia)...

Assuntos

RESUMO

The objective of the present study was to evaluate the effect of treatment with prosta-glandin F2α (PGF2α) at the beginning of the protocol for ovulation synchronization on follicular dy-namics in Bos indicus (Gyr; n=11), Bos taurus (Holstein Black and White, HBW; n=10), and crossbred animals (Gyr x HBW; n=12). On a random day of the estrous cycles (day 0, D0), the animals received 2.0 mg estradiol benzoate (EB) intramuscularly plus an intravaginal progesterone (P4) device, which was maintained for 8 days (day 8, D8). Half the heifers of each group received a dose of 25 mg PGF2αintramuscularly at the time of insertion of the intravaginal P4 device. When the intravaginal device was removed (D8), all animals received another dose of 25 mg PGF2α intramuscularly, followed by intramuscular injection of 1.0 mg EB 24 h later (day 9, D9). Ultrasonographic evaluations were per-formed at intervals of 24 hours from D0 to D8 and at intervals of 12 hours from removal of the P4 device to 96 hours thereafter. Samples were collected on days 0, 3, 6, 8, 10 and 22 for the measurement of P4. The mean maximum diameter of the dominant follicle (DF) was smaller (P=0.01) in Gyr heifers (10.0 ± 0.8 mm) than in Gyr x HBW (13.0 ± 0.6 mm) or HBW (12.5 ± 0.8 mm). Furthermore, treatment with PGF2α on D0 increased (P=0.02) the maximum diameter of DF (12.9 ± 0.5 vs. 10.9 ± 0.7 mm)...(AU)

O objetivo do presente estudo foi avaliar o efeito do tratamento com prostaglandina F2α (PGF2α)no início do protocolo de sincronização da ovulação, sobre a dinâmica folicular de novilhas Bos indicus (Gir; n=11), Bos taurus (Holandesa Preto e Branco - HPB; n=10) e cruzadas (Gir x HPB; n=12). Em dia aleatório do ciclo estral (dia 0 - D0), os animais receberam 2,0 mg de benzoato de es-tradiol (BE) via intramuscular, mais um dispositivo intravaginal de progesterona (P4) que foi man-tido por oito dias (dia 8 D8). Metade das novilhas de cada grupo recebeu uma dose de 25 mg de PGF2α via intramuscular no momento da inserção do dispositivo intravaginal de P4. Na retirada do dispositivo intravaginal (D8), todos os animais receberam outra dose de 25 mg de PGF2α via intra-muscular e 24 h após (dia 9 - D9) receberam 1,0 mg de BE via intramuscular. Foram realizadas ava-liações ultrassonográficas com intervalos de 24 horas do D0 até o D8 e com intervalos de 12 horas da retirada do dispositivo de P4 até 96 horas. Para a dosagem de P4, foram colhidas amostras nos dias 0; 3; 6; 8; 10 e 22. A média do diâmetro máximo do folículo dominante (FD) foi menor (P=0,01) nas novilhas Gir (10,0 ± 0,8 mm) do que nas cruzadas Gir x HPB (13,0 ± 0,6 mm) ou HPB (12,5 ± 0,8 mm). Além disso, o tratamento com PGF2α no D0 aumentou (P=0,02) o diâmetro máximo do FD (12,9 ± 0,5 mm vs. 10,9 ± 0,7 mm) nos três grupamentos genéticos avaliados. A taxa de crescimento do FD foi menor (P=0,008) nas novilhas Gir (0,8 ± 0,1 mm/dia), do que nas novilhas cruzadas (1,3 ± 0,1 mm/dia) ou HPB (1,2 ± 0,1 mm/dia)...(AU)

Assuntos

RESUMO

The aim of this study was to evaluate the effects of GnRH, LH, hCG or exogenous progesterone administration on plasma progesterone concentrations and pregnancy rates following embryo transfer in Bos taurus x Bos indicus cross-bred heifers. In Experiment 1, animals with body condition scores  3.5 (1 to 5 scale) were synchronized with two injections of a prostaglandin F2  analog 13 days apart. He ifers detected in estrus (day 0; n = 37) were randomly assigned on day 7 to receive one of five treatments: Control (2 ml saline im; n = 6), GnRH (10  g Buserelin im; n = 8), hCG (1500 IU Chorulon im; n = 8), LH (25 mg pLH im; n = 7) or a CIDR-B device for 13 days (n = 8). Ovarian ultrasonography was performed daily from day 6 until the subsequent estrus. Heifers in the GnRH, hCG and LH groups were evaluated every 12 h between days 7 and 9 to confirm ovulation of the first-wave dominant follicle. Blood samples were collected daily for determination of P4 levels. Estrus detection was performed daily with the aid of androgenized cows. Ovulation rate for the first wave dominant follicle was 100% for heifers treated with GnRH, hCG and LH. Between days 13 and 17, the mean diameter of original CLs, diameter of accessory CLs and P4 concentrations were greater in heifers treated with hCG than in heifers in all other groups (P < 0.05). Duration of the luteal phase (number of days with a P4 concentration  1.0 ng/ml) was similar in hCG (14.3 ± 0.6), LH (13.4 ± 0.6), GnRH (13.4 ± 0.4), CIDR-B (14.5 ± 0.2) and Control (12.8 ± 0.5) groups. In Experiment 2, animals were kept on a grazing regimen at commercial farms in Brazil and were synchronized with one injection of a prostaglandin F2  analog. The same hormonal treatments as in Experiment 1 were given on day 7 after estrus at the time of transfer of frozen/thawed embryos to Bos taurus x Bos indicus recipients (n = 485). Pregnancy rates were higher in GnRH- (53.5%; 53/99) and hCG- (51.0%; 49/96) treated heifers (P < 0.05) than in control heifers (28.6%; 28/98), but were similar to heifers treated with CIDR devices (41.1%; 39/95) and LH (45.4%; 44/97). It was concluded that the improvement in conception rates in hCG treated Bos taurus x Bos indicus cross-bred heifers receiving frozen/thawed embryos were due to both P4-dependent and P4-independent mechanisms.(AU)

Assuntos

RESUMO

The aim of this study was to evaluate the effects of GnRH, LH, hCG or exogenous progesterone administration on plasma progesterone concentrations and pregnancy rates following embryo transfer in Bos taurus x Bos indicus cross-bred heifers. In Experiment 1, animals with body condition scores  3.5 (1 to 5 scale) were synchronized with two injections of a prostaglandin F2  analog 13 days apart. He ifers detected in estrus (day 0; n = 37) were randomly assigned on day 7 to receive one of five treatments: Control (2 ml saline im; n = 6), GnRH (10  g Buserelin im; n = 8), hCG (1500 IU Chorulon im; n = 8), LH (25 mg pLH im; n = 7) or a CIDR-B device for 13 days (n = 8). Ovarian ultrasonography was performed daily from day 6 until the subsequent estrus. Heifers in the GnRH, hCG and LH groups were evaluated every 12 h between days 7 and 9 to confirm ovulation of the first-wave dominant follicle. Blood samples were collected daily for determination of P4 levels. Estrus detection was performed daily with the aid of androgenized cows. Ovulation rate for the first wave dominant follicle was 100% for heifers treated with GnRH, hCG and LH. Between days 13 and 17, the mean diameter of original CLs, diameter of accessory CLs and P4 concentrations were greater in heifers treated with hCG than in heifers in all other groups (P < 0.05). Duration of the luteal phase (number of days with a P4 concentration  1.0 ng/ml) was similar in hCG (14.3 ± 0.6), LH (13.4 ± 0.6), GnRH (13.4 ± 0.4), CIDR-B (14.5 ± 0.2) and Control (12.8 ± 0.5) groups. In Experiment 2, animals were kept on a grazing regimen at commercial farms in Brazil and were synchronized with one injection of a prostaglandin F2  analog. The same hormonal treatments as in Experiment 1 were given on day 7 after estrus at the time of transfer of frozen/thawed embryos to Bos taurus x Bos indicus recipients (n = 485). Pregnancy rates were higher in GnRH- (53.5%; 53/99) and hCG- (51.0%; 49/96) treated heifers (P < 0.05) than in control heifers (28.6%; 28/98), but were similar to heifers treated with CIDR devices (41.1%; 39/95) and LH (45.4%; 44/97). It was concluded that the improvement in conception rates in hCG treated Bos taurus x Bos indicus cross-bred heifers receiving frozen/thawed embryos were due to both P4-dependent and P4-independent mechanisms.

Assuntos

RESUMO

Two experiments were conducted to investigate the effects of equine chorionic gonadotropin (eCG) at progestin removal and gonadotropin-releasing hormone (GnRH) at timed artificial insemination (TAI) on ovarian follicular dynamics (Experiment 1) and pregnancy rates (Experiment 2) in suckled Nelore (Bos indicus) cows. Both experiments were 2x2 factorials (eCG or No eCG, and GnRH or No GnRH), with identical treatments. In Experiment 1, 50 anestrous cows, 134.5+/-2.3 d postpartum, received a 3mg norgestomet ear implant sc, plus 3mg norgestomet and 5mg estradiol valerate im on Day 0. The implant was removed on Day 9, with TAI 54 h later. Cows received 400 IU eCG or no further treatment on Day 9 and GnRH (100 microg gonadorelin) or no further treatment at TAI. Treatment with eCG increased the growth rate of the largest follicle from Days 9 to 11 (means+/-SEM, 1.53+/-0.1 vs. 0.48+/-0.1mm/d; P<0.0001), its diameter on Day 11 (11.4+/-0.6 vs. 9.3+/-0.7 mm; P=0.03), as well as ovulation rate (80.8% vs. 50.0%, P=0.02), whereas GnRH improved the synchrony of ovulation (72.0+/-1.1 vs. 71.1+/-2.0 h). In Experiment 2 (n=599 cows, 40 to 120 d postpartum), pregnancy rates differed (P=0.004) among groups (27.6%, 40.1%, 47.7%, and 55.7% for Control, GnRH, eCG, and eCG+GnRH groups). Both eCG and GnRH improved pregnancy rates (51.7% vs. 33.8%, P=0.002; and 48.0% vs 37.6%, P=0.02, respectively), although their effects were not additive (no significant interaction). In conclusion, eCG at norgestomet implant removal increased the growth rate of the largest follicle (LF) from implant removal to TAI, the diameter of the LF at TAI, and rates of ovulation and pregnancy rates. Furthermore, GnRH at TAI improved the synchrony of ovulations and pregnancy rates in postpartum Nelore cows treated with a norgestomet-based TAI protocol.

Assuntos

RESUMO

The objective of this study was to evaluate the effects of treatment with an intravaginal progesterone-releasing device (CIDR) and estradiol benzoate (EB) on follicular dynamics in Bos indicus (n=23), Bos taurus (n=25), and cross-bred (n=23) heifers. To assess the influence of reduced serum progesterone concentrations during 8 days of treatment with a progesterone-releasing device on follicular dynamics, half of the heifers received PGF at CIDR insertion (Day 0; 3 x 2 factorial design). Mean (+/-S.E.M.) serum progesterone concentrations during CIDR treatment varied (P<0.05) among genetic groups: B. indicus (5.4+/-0.1 ng/mL), B. taurus (3.3+/-0.0 ng/mL), and cross-bred (4.3+/-0.1 ng/mL). Maximum diameter of the dominant follicle (DF) was smaller (P<0.01) in B. indicus heifers (9.5+/-0.5 mm) than in cross-bred (12.3+/-0.4 mm) or B. taurus heifers (11.6+/-0.5 mm). B. indicus experienced lower (P<0.01) ovulation rate (39.1%) than did B. taurus (72.7%) and cross-bred (84.0%). Heifers treated with PGF on Day 0 had lower (P<0.05) serum progesterone concentrations during progesterone treatment. The PGF treatment on Day 0 increased (P<0.01) the diameter of the DF (11.9+/-0.4 mm vs. 10.5+/-0.4 mm). Moreover, greater (P=0.02) ovulation rates (78.8 vs. 54.0%) occurred in heifers treated with PGF on Day 0. In summary, B. indicus heifers had greater serum progesterone concentrations, smaller DF diameter, and a lower ovulation rate compared to B. taurus heifers. Prostaglandin treatment on the day of CIDR insertion reduced serum progesterone during treatment, and resulted in increased maximum DF diameter and ovulation rate.

Assuntos

RESUMO

The objective was to evaluate the effects of 400 IU of eCG given on Days 5 or 8 of an estrus synchronization protocol with progesterone-releasing intravaginal devices (PRID) and estradiol benzoate (EB), in recipients for fixed-time embryo transfer. A secondary objective was to determine the effects of injectable progesterone (given concurrent with EB treatment). Three-hundred-and-four crossbred Bos taurus x Bos indicus beef heifers were randomly assigned to one of four treatment groups (2 x 2 factorial design). At unknown stages of the estrous cycle (Day 0), all heifers received a progesterone-releasing intravaginal device (PRID), plus 2mg of EB i.m., with or without a concurrent treatment of 50mg of progesterone i.m. Heifers were further subdivided to receive 0.15 mg of d-cloprostenol (PGF) i.m. and 400 IU of eCG i.m. on Days 5 or 8. In all heifers, intravaginal devices were removed on Day 8 and 1mg of EB was given i.m. on Day 9 (Day 10 was arbitrarily considered the day of estrus). On Day 17, all heifers with >1 CL or a single CL with a diameter > or =18 mm (based on ultrasonographic examination), received an in vitro produced (IVP) embryo by non-surgical transfer. On Day 17, there was an effect of day of eCG administration on the number of CL (1.35 +/- 0.08 versus 1.13 +/- 0.04, for Day 5 versus Day 8, respectively; P = 0.02) and (in a subset of 154 heifers) mean (+/-S.E.M.) plasma progesterone concentrations (2.41 +/- 0.26 versus 1.74 +/- 0.19 ng/mL; P = 0.03). Although the proportion of recipients transferred/treated and pregnant/transferred did not differ among groups, the proportion of recipients pregnant/treated tended (P = 0.1) to be higher in heifers treated with eCG on Day 5 versus Day 8 (47.0% versus 40.7%, respectively). Progesterone treatment had no significant effect. In conclusion, treatment with eCG (and D-cloprostenol) on Day 5 significantly increased the number of CL and plasma progesterone concentrations and tended to increase pregnancy rates, although progesterone treatment had no significant effect.

Assuntos

RESUMO

Most of the world's bovine herd is found in tropical regions. Bos indicus predominates, due to their adaptation to the climate and management conditions. Anestrous is the main factor that negatively affects reproductive performance of animals bred in these regions of the globe. Several factors affect postpartum anestrous, including suckling and maternal-offspring bond, and pre- and postpartum nutritional status. The short duration of estrus and the tendency to show estrus during the night, greatly affect the efficiency of artificial insemination (AI) programs in B. indicus cattle managed in tropical areas. Several restricted suckling or weaning procedures (temporary or permanent), and hormonal treatments have been used to induce ovulation and cyclicity in postpartum cows. Most hormonal treatments are based on progesterone/progestogen (P4) releasing devices associated with estradiol benzoate (EB), or a combination of GnRH/PGF(2alpha)/GnRH (Ovsynch). Treatments with GnRH/PGF(2alpha)/GnRH has presented inconsistent results, probably due to the variable number of cows in anestrous. Treatments using P4 devices and EB have resulted in apparently more consistent results than Ovsynch programs in B. indicus cattle; however, pregnancy rates are low in herds presenting high anestrous rates and moderate to low body condition. The addition of an eCG treatment at the time of device removal, which increased plasma progesterone concentrations and pregnancy rates in anestrous postpartum suckled B. indicus cows, may be useful to improve reproductive performance of beef cattle in tropical climates.

Assuntos